A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
Chen, Li-Tzong, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Sameshima, Hiroki, Kang, Yoon-Koo, Boku, Narikazu
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2020)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2020)
Get full text
Journal Article
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Kang, Yoon-Koo, Boku, Narikazu, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Chen, Li-Tzong
Published in The Lancet (British edition) (02.12.2017)
Published in The Lancet (British edition) (02.12.2017)
Get full text
Journal Article
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Qin, Shukui, Bai, Yuxian, Lim, Ho Yeong, Thongprasert, Sumitra, Chao, Yee, Fan, Jia, Yang, Tsai-Shen, Bhudhisawasdi, Vajarabhongsa, Kang, Won Ki, Zhou, Yu, Lee, Jee Hyun, Sun, Yan
Published in Journal of clinical oncology (01.10.2013)
Published in Journal of clinical oncology (01.10.2013)
Get full text
Journal Article
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Yau, Thomas, Hsu, Chiun, Kim, Tae-You, Choo, Su-Pin, Kang, Yoon-Koo, Hou, Ming-Mo, Numata, Kazushi, Yeo, Winnie, Chopra, Akhil, Ikeda, Masafumi, Kuromatsu, Ryoko, Moriguchi, Michihisa, Chao, Yee, Zhao, Huanyu, Anderson, Jeffrey, Cruz, Christine Dela, Kudo, Masatoshi
Published in Journal of hepatology (01.09.2019)
Published in Journal of hepatology (01.09.2019)
Get full text
Journal Article
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
Lee, Pei-Chang, Chao, Yee, Chen, Ming-Huang, Lan, Keng-Hsin, Lee, Chieh-Ju, Lee, I-Cheng, Chen, San-Chi, Hou, Ming-Chih, Huang, Yi-Hsiang
Published in Cancers (11.01.2020)
Published in Cancers (11.01.2020)
Get full text
Journal Article
A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
Lee, I‐Cheng, Hung, Ya‐Wen, Liu, Chien‐An, Lee, Rheun‐Chuan, Su, Chien‐Wei, Huo, Teh‐Ia, Li, Chung‐Pin, Chao, Yee, Lin, Han‐Chieh, Hou, Ming‐Chih, Huang, Yi‐Hsiang
Published in Liver international (01.09.2019)
Published in Liver international (01.09.2019)
Get full text
Journal Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
Boku, Narikazu, Satoh, Taroh, Ryu, Min-Hee, Chao, Yee, Kato, Ken, Chung, Hyun Cheol, Chen, Jen-Shi, Muro, Kei, Kang, Won Ki, Yeh, Kun-Huei, Yoshikawa, Takaki, Oh, Sang Cheul, Bai, Li-Yuan, Tamura, Takao, Lee, Keun-Wook, Hamamoto, Yasuo, Kim, Jong Gwang, Chin, Keisho, Oh, Do-Youn, Minashi, Keiko, Cho, Jae Yong, Tsuda, Masahiro, Nishiyama, Taihei, Chen, Li-Tzong, Kang, Yoon-Koo
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2021)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2021)
Get full text
Journal Article
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
Catenacci, Daniel V T, Kang, Yoon-Koo, Park, Haeseong, Uronis, Hope E, Lee, Keun-Wook, Ng, Matthew C H, Enzinger, Peter C, Park, Se Hoon, Gold, Philip J, Lacy, Jill, Hochster, Howard S, Oh, Sang Cheul, Kim, Yeul Hong, Marrone, Kristen A, Kelly, Ronan J, Juergens, Rosalyn A, Kim, Jong Gwang, Bendell, Johanna C, Alcindor, Thierry, Sym, Sun Jin, Song, Eun-Kee, Chee, Cheng Ean, Chao, Yee, Kim, Sunnie, Lockhart, A Craig, Knutson, Keith L, Yen, Jennifer, Franovic, Aleksandra, Nordstrom, Jeffrey L, Li, Daner, Wigginton, Jon, Davidson-Moncada, Jan K, Rosales, Minori Koshiji, Bang, Yung-Jue
Published in The lancet oncology (01.08.2020)
Published in The lancet oncology (01.08.2020)
Get full text
Journal Article
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma
Lu, Zhihao, Yang, Silu, Luo, Xuerui, Shi, Yang, Lee, Jong-Seok, Deva, Sanjeev, Liu, Tianshu, Chao, Yee, Zhang, Yun, Huang, Ruiqi, Xu, Yaling, Shen, Zhirong, Shen, Lin
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.09.2022)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.09.2022)
Get full text
Journal Article
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
LLOVET, Josep M, DECAENS, Thomas, MATHURIN, Philippe, FARTOUX, Laetitia, LIN, Deng-Yn, BRUIX, Jordi, POON, Ronnie T, SHERMAN, Morris, BLANC, Jean-Frédéric, FINN, Richard S, TAK, Won-Young, YEE CHAO, RAOUL, Jean-Luc, EZZEDDINE, Rana, LIU, David, WALTERS, Ian, PARK, Joong-Won, BOUCHER, Eveline, KUDO, Masatoshi, CHANG, Charissa, KANG, Yoon-Koo, ASSENAT, Eric, LIM, Ho-Yeong, BOIGE, Valerie
Published in Journal of clinical oncology (01.10.2013)
Published in Journal of clinical oncology (01.10.2013)
Get full text
Journal Article
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study
Chen, San-Chi, Huang, Yi-Hsiang, Chen, Ming-Huang, Hung, Yi-Ping, Lee, Rheun-Chuan, Shao, Yu-Yun, Chao, Yee
Published in BMC cancer (11.01.2022)
Published in BMC cancer (11.01.2022)
Get full text
Journal Article
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
Desai, Jayesh, Deva, Sanjeev, Lee, Jong Seok, Lin, Chia-Chi, Yen, Chia-Jui, Chao, Yee, Keam, Bhumsuk, Jameson, Michael, Hou, Ming-Mo, Kang, Yoon-Koo, Markman, Ben, Lu, Chang-Hsien, Rau, Kun-Ming, Lee, Kyung-Hun, Horvath, Lisa, Friedlander, Michael, Hill, Andrew, Sandhu, Shahneen, Barlow, Paula, Wu, Chi-Yuan, Zhang, Yun, Liang, Liang, Wu, John, Paton, Virginia, Millward, Michael
Published in Journal for immunotherapy of cancer (01.06.2020)
Published in Journal for immunotherapy of cancer (01.06.2020)
Get full text
Journal Article
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
JOHNSON, Philip J, SHUKUI QIN, LIGONG LU, CHAO, Yee, BOUCHER, Eveline, HAN, Kwang-Hyub, PAIK, Seung-Woon, ROBLES-AVINA, Jorge, KUDO, Masatoshi, LUNAN YAN, SOBHONSLIDSUK, Abhasnee, KOMOV, Dmitry, PARK, Joong-Won, DECAENS, Thomas, TAK, Won-Young, JENG, Long-Bin, LIU, David, EZZEDDINE, Rana, WALTERS, Ian, CHENG, Ann-Lii, POON, Ronnie T. P, RAOUL, Jean-Luc, PHILIP, Philip A, HSU, Chih-Hung, HU, Tsung-Hui, HEO, Jeong, JIANMING XU
Published in Journal of clinical oncology (01.10.2013)
Published in Journal of clinical oncology (01.10.2013)
Get full text
Journal Article
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
VAN CUTSEM, Eric, MOISEYENKO, Vladimir M, RISSE, Marie-Laure, AJANI, Jaffer A, TJULANDIN, Sergei, MAJLIS, Alejandro, CONSTENLA, Manuel, BONI, Corrado, RODRIGUES, Adriano, FODOR, Miguel, CHAO, Yee, VOZNYI, Edouard
Published in Journal of clinical oncology (01.11.2006)
Published in Journal of clinical oncology (01.11.2006)
Get full text
Journal Article
Survival outcomes of management in metastatic gastric adenocarcinoma patients
Hu, Huang-Ming, Tsai, Hui-Jen, Ku, Hsiu-Ying, Lo, Su-Shun, Shan, Yan-Shen, Chang, Hung-Chi, Chao, Yee, Chen, Jen-Shi, Chen, Shu-Chen, Chiang, Chun-Ju, Li, Anna Fen-Yau, Wang, Hsiu-Po, Wang, Tsang-En, Bai, Li-Yuan, Wu, Ming-Shiang, Chen, Li-Tzong, Liu, Tsang-Wu, Yang, Yi-Hsin
Published in Scientific reports (30.11.2021)
Published in Scientific reports (30.11.2021)
Get full text
Journal Article
Outcomes of patients with malignant duodenal obstruction after receiving self-expandable metallic stents: A single center experience
Wei, Tien-Hsin, Ye, Bing-Wei, Wu, Pei-Shan, Li, Chung-Pin, Chao, Yee, Lee, Pei-Chang, Huang, Yi-Hsiang, Lee, Kuei-Chuan, Hou, Ming-Chih
Published in PloS one (25.05.2022)
Published in PloS one (25.05.2022)
Get full text
Journal Article
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion
Tobias, Joshua, Högler, Sandra, Raigel, Martin, Lin, Diego Shih-Chieh, Chao, Yee, Kenner, Lukas, Garner-Spitzer, Erika, Yavrom, Sharon, Ede, Nicholas J, Zielinski, Christoph C, Kundi, Michael, Wiedermann, Ursula
Published in International journal of molecular sciences (24.12.2023)
Published in International journal of molecular sciences (24.12.2023)
Get full text
Journal Article
Surgical resection could provide better outcomes for patients with hepatocellular carcinoma and tumor rupture
Lee, Chun-Yang, Chau, Gar-Yang, Wei, Cheng-Yi, Chao, Yee, Huang, Yi-Hsiang, Huo, Teh-Ia, Hou, Ming-Chih, Su, Yu-Hui, Wu, Jaw-Ching, Su, Chien-Wei
Published in Scientific reports (18.05.2022)
Published in Scientific reports (18.05.2022)
Get full text
Journal Article